Pertuzumab + trastuzumab for HER2-amplified/overexpressed metastatic colorectal cancer (mCRC): Interim data from MyPathway.
暂无分享，去创建一个
J. Hainsworth | R. Bose | C. Swanton | F. Meric-Bernstam | R. Kurzrock | H. Hurwitz | M. Fakih | H. Burris | M. Beattie | C. Bernaards | C. Sweeney | D. Spigel | A. Vanderwalde | K. Raghav | N. Sommer | Shuangli Guo